AzTrials
AzTrials

Physical InactivityPhase 2NCT05285748

Comparing Self-paced Versus Moderate Intensity Physical Activity Recommendation for Midlife Adults

A Phase 2 study testing Self-Paced Intensity Physical Activity and Prescribed Moderate Intensity Physical Activity in people with Physical Inactivity, run by Brown University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

We will randomly assign (blocked on Gender (female, male, other), body mass index (BMI; overweight [25 < BMI < 30]) or obese (30 < BMI <40) and pain status (chronic pain vs not)) adults ages 50-64 into either; (a) self-selected intensity (i.e., SELF-PACED) or (b) prescribed moderate intensity (i.e., PRESCRIBED)… Read more about this study

Who is it for?
Ages 50 to 64 yearsHealthy volunteers can take part
Conditions the study is for
Physical Inactivity
What is being tested?
Self-Paced Intensity Physical Activity and Prescribed Moderate Intensity Physical Activity
Could I receive a placebo?
No, everyone receives an active treatment
How many people
258 participants
Where
1 siteUnited States
Study dates
15 Mar 2022to 31 May 2026
Phase
Phase 2
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 to 64 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • ages 50-64
  • BMI 25-40
  • Sedentary or low-active, defined as participating in < 60 min/week of structured exercise
  • Has a smart phone that can connect to the internet at least once every few days and is compatible with smartphone app

Who cannot join

  • Medical symptoms/conditions that may make unsupervised exercise unsafe (specific exclusion criteria were developed in consultation with a cardiologist and are listed below):
  • Past 3-month overnight hospitalization
  • Past 3-month treatment for heart disease, including bypass or valve surgery, interventional procedure(s) such as angioplasty (stent), or a pacemaker or other implanted device to control your heart rate or rhythm
  • Past 3-month inability to walk without assistance due to stroke, transient ischemic attack (TIA), or neurologic or spinal injury
  • Past 6-month angina, chest pain, or chest discomfort either at rest or with exertion/activity
  • Past 6-month peripheral vascular disease such as claudication which causes pain in the legs when walking briskly
Show all 28Show fewer
  • Past 6-month seizure
  • Past 6-month overnight hospitalization due to respiratory disease
  • Past 6-month lightheadedness, vertigo, dizziness, or fainting
  • Heart, lung, abdominal, joint, or orthopedic surgeries in the past 12-months, or pending or scheduled in the next 12 months
  • Takes insulin and/or medication that affects the secretion of insulin
  • Exercise-induced asthma that prevents brisk walking
  • Takes anticonvulsant medication or medication to treat/control seizures
  • Diagnosed with cystic fibrosis
  • Bone or joint problems that make you unable to walk for at least 30 minutes
  • Physician has said not to exercise because of bone or joint problems
  • Physician has said a hip or knee replacement will be needed in the next 12 months
  • Anything other medical symptoms/condition that prevents participant from being physical unable to walk without assistance continuously for 30 minutes
  • Currently taking or planning on taking medications that affect HR, such as beta or calcium channel blockers or digoxin, as HR will be used to determine the moderate intensity range for participants assigned to that condition
  • Past 12-month overnight psychiatric hospitalization
  • Currently pregnant or planning to become pregnant in the next year
  • Currently participating in any exercise or weight-loss research studies
  • Household member is participating in this study
  • Does not have a Rhode Island mailing address OR if only Rhode Island mailing address is a PO box
  • Unable to receive materials in the mail at residential mailing address
  • Does not plan to live in Rhode Island for the next 12 months
  • Unable to speak, read, and/or write fluently in English
  • Smokers will be eligible, but smoking status will be included as a covariate in analyses

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Brown University

    Providence, Rhode Island, 02912

Other trials in United States

About this study

Official title: Comparing a Recommendation for Self-paced Versus Moderate Intensity Physical Activity for Midlife Adults: an RCT

We will randomly assign (blocked on Gender (female, male, other), body mass index (BMI; overweight [25 < BMI < 30]) or obese (30 < BMI <40) and pain status (chronic pain vs not)) adults ages 50-64 into either; (a) self-selected intensity (i.e., SELF-PACED) or (b) prescribed moderate intensity (i.e., PRESCRIBED) conditions. Prior to randomization, persons responding to our ads will participate in the following: (1) telephone screening with the study research assistant (RA) to establish eligibility; (2) an orientation session to obtain more information about the study; and, after providing informed consent (3) baseline assessment and screening (bodyweight, maximal fitness test, dietary intake, and questionnaires to assess potential covariates). Prior to randomization, the RA will give participants an accelerometer to assess baseline physical activity (PA) behavior over a one-week period. Participants will then be randomized to one of the two study conditions. Following randomization, all participants will receive our theory-based PA promotion intervention to help them overcome barriers to regular PA. All participants will be given chest strap heart rate (HR) monitors and instructions on wrist palpation. Follow-up assessments will consist of accelerometry for one-week periods at months 3, 6, 9, and 12, ecological momentary assessment (EMA) throughout the 12 months and bodyweight at 3-month intervals.

Being tested
Self-Paced Intensity Physical Activity, Prescribed Moderate Intensity Physical Activity
Keywords
Physical activity, Exercise, Self-pacing
Medical subject headings
Sedentary Behavior, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Self-Paced Intensity Physical ActivityBehavioural

    Participants are given a prescription to engage in 150-300 minutes per week of structured exercise with an emphasis on walking. For this study arm, participants are given the explicit recommendation to engage in self-selected intensity PA.

  • Prescribed Moderate Intensity Physical ActivityBehavioural

    Participants are given a prescription to engage in 150-300 minutes per week of structured exercise with an emphasis on walking. For this study arm, participants are given the explicit recommendation to engage in moderate intensity PA consistent with national guidelines.

Study groups in NCT05285748
Study groupRoleWhat they receive
Self-Paced Intensity Physical ActivityExperimentalNot described
Receives: Behavioral: Self-Paced Intensity Physical Activity
Prescribed Moderate Intensity Physical ActivityActive comparatorNot described
Receives: Behavioral: Prescribed Moderate Intensity Physical Activity

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in total volume of structured PA

    Minutes of PA weighted by intensity, expressed in metabolic equivalent (MET) minutes as determined by accelerometers (Actigraph [model wGT3x-BT]) worn during one-week periods.

    Measured: Measured at baseline, and months 3, 6, 9, and 12.

  2. Minutes per week of PA

    Participants will be instructed to indicate, in real time, each time they begin and end a PA session via EMA.

    Measured: Measured daily from date of randomization for 52 weeks based on participant initiation of exercise

Secondary outcomes (1)
  1. Changes in Body Weight

    Assessment of self-reported body weight by study-provided scales

    Measured: Measured at baseline, and months 3, 6, 9, and 12.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Mar 2022
  2. Study start15 Mar 2022
  3. Primary completion31 May 2026
  4. Study completion31 May 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
258 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05285748
Sponsor's protocol ID
R01AG069349
Other IDs
F32AG074680
Status last verified
Sep 2026
First submitted
23 Feb 2022
Last updated
16 Sep 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A Phase 2 study testing Self-Paced Intensity Physical Activity and Prescribed Moderate Intensity Physical Activity in people with Physical Inactivity, run by Brown University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 28 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in total volume of structured PA (time frame: Measured at baseline, and months 3, 6, 9, and 12.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Sep 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in